It's time for chronotherapy!

European Journal of Cancer

Volumn 38, Issue SUPPL. 4, 2002, Pages 50-53

  Coudert, B ^a   Focan, C ^b   Donato di Paola, E ^c   Lévi, F ^d  

^a CENTRE GEORGES FRANÇOIS LECLERC   (France)

^b Clinique Saint Joseph   (Belgium)

^c EORTC DATA CENTER   (Belgium)

^d HÔPITAL PAUL BROUSSE   (France)

Author keywords

Chronobiology; Chronoefficacy; Chronotherapy; Chronotolerance; Circadian rhythms

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRINOTECAN; NAVELBINE; OXALIPLATIN;

ACTIMETRY; BIOLOGICAL RHYTHM; CANCER RESEARCH; CANCER SURVIVAL; CANCER THERAPY; CHRONOBIOLOGY; CHRONOTHERAPY; CIRCADIAN RHYTHM; CLINICAL TRIAL; DEVICE; DRUG DELIVERY SYSTEM; DRUG SCREENING; HEALTH CARE ORGANIZATION; HUMAN; INTERNATIONAL COOPERATION; ORGANIZATION; PRIORITY JOURNAL; PUMP; QUALITY OF LIFE; REVIEW;

EID: 0036180310     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0959-8049(01)00447-6     Document Type: Review

References (26)

1. Chronomodulated versus fixed infusion rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil and folinic acid (leucovorin) in patients with colorectal cancer metastases: A randomized multi-institutional trial
2. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer
3. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer
4. Chemotherapy of advanced ovarian cancer with 4-O-tetrahydropyranyl doxorubicin and cisplatin: A randomized phase II trial with an evaluation of circadian timing and dose intensity
5. Circadian rhythm-modulated chemotherapy with high dose 5-fluorouracil: A pilot study in patients with pancreatic adenocarcinoma
6. Circadian rythm-modulated (CRM) chemotherapy of metastatic breast cancer with mitoxantrone, 5-fluorouracil and folinic acid: Preliminary results of a phase I trial
7. Marker rhythms for cancer chronotherapy. From laboratory animals to human beings
8. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
9. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status
10. Chronomodulation: Optimal time finding design. 22nd Annual Meeting of the Society for Clinical Trials
11. Circadian concepts in normal and neoplastic breast
12. Chronobiological concepts underlying the chronotherapy of human lung cancer
13. Circadian chronotherapy for human cancers
14. Chronomodulation of chemotherapy against metastatic colorectal cancer
15. Rhythms of cancer chemotherapy
16. Tumor based rhythms of anticancer efficacy in experimental models
17. Pharmacological effects of vinorelbine on body temperature and locomotor activity circadian rhythms in mice
18. Rhythms in human gastrointestinal mucosa and skin
19. Rhythms in human bone marrow and blood cells
20. Circadian rhythms of DNA synthesis in nasopharyngeal carcinoma cells
21. Marker rhythms of circadian system function: A study of patients with metastatic colorectal cancer and good performance status
22. Contribution of the rest activity circadian rhythm to quality of life in cancer patients
23. Quality of life and chronotherapy
24. Pharmaco-economic comparative evaluation of combination chronotherapy versus standard chemotherapy for colorectal cancer